GB202009981D0 - Method - Google Patents

Method

Info

Publication number
GB202009981D0
GB202009981D0 GBGB2009981.8A GB202009981A GB202009981D0 GB 202009981 D0 GB202009981 D0 GB 202009981D0 GB 202009981 A GB202009981 A GB 202009981A GB 202009981 D0 GB202009981 D0 GB 202009981D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2009981.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xced LLP
Original Assignee
Xced LLP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xced LLP filed Critical Xced LLP
Priority to GBGB2009981.8A priority Critical patent/GB202009981D0/en
Publication of GB202009981D0 publication Critical patent/GB202009981D0/en
Ceased legal-status Critical Current

Links

GBGB2009981.8A 2020-06-30 2020-06-30 Method Ceased GB202009981D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2009981.8A GB202009981D0 (en) 2020-06-30 2020-06-30 Method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2009981.8A GB202009981D0 (en) 2020-06-30 2020-06-30 Method

Publications (1)

Publication Number Publication Date
GB202009981D0 true GB202009981D0 (en) 2020-08-12

Family

ID=71949673

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2009981.8A Ceased GB202009981D0 (en) 2020-06-30 2020-06-30 Method

Country Status (1)

Country Link
GB (1) GB202009981D0 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003077785A1 (en) 2002-03-12 2003-09-25 Steven Streatfield Gill Catheter and guide tube for intracerebral application
WO2008062173A1 (en) 2006-11-23 2008-05-29 Renishaw Plc Neurological apparatus comprising a percutaneous access device
WO2011098769A1 (en) 2010-02-12 2011-08-18 Renishaw (Ireland) Limited Percutaneous drug delivery apparatus
WO2014184576A2 (en) 2013-05-17 2014-11-20 Renishaw Plc Delivery

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003077785A1 (en) 2002-03-12 2003-09-25 Steven Streatfield Gill Catheter and guide tube for intracerebral application
WO2008062173A1 (en) 2006-11-23 2008-05-29 Renishaw Plc Neurological apparatus comprising a percutaneous access device
WO2011098769A1 (en) 2010-02-12 2011-08-18 Renishaw (Ireland) Limited Percutaneous drug delivery apparatus
WO2014184576A2 (en) 2013-05-17 2014-11-20 Renishaw Plc Delivery

Non-Patent Citations (28)

* Cited by examiner, † Cited by third party
Title
BENNY KLIMEK ME ET AL., PLOS ONE, vol. 11, no. 5, 23 May 2016 (2016-05-23), pages e0155944
BRANTLY ML ET AL., PROC. NATL ACAD. SCI. USA., vol. 106, no. 38, 2009, pages 16363 - 8
DE JONG YP ET AL., SCI TRANSL MED., vol. 6, no. 254, 2014, pages 254ra129
DEAL C ET AL., PROC. NATL. ACAD. SCI. USA., vol. 111, no. 34, 2014, pages 12528 - 12532
FONOFF ET ET AL., BEHAV BRAIN RES., vol. 202, no. 1, 2009, pages 138 - 41
GAUDET D ET AL., GENE THER., vol. 20, no. 4, 2013, pages 361 - 9
GILL T ET AL., J NEUROSCI METHODS, vol. 219, no. 1, 2013, pages 1 - 9
GUO ET AL., NATURE COMMUNICATIONS, vol. 8, 2017, pages 861
HAGSTROM JE ET AL., MOL. THER., vol. 10, no. 2, 2004, pages 386 - 98
HASHIZUME ET AL., INT REV IMMUNOL., vol. 34, no. 3, May 2015 (2015-05-01), pages 265 - 79
HINDERER C ET AL., HUMAN GENE THERAPY, vol. 29, no. 3, January 2018 (2018-01-01), pages 285 - 296
HO DT ET AL., CANCER GENE THER., vol. 15, no. 9, 2008, pages 553 - 62
HUDRY E ET AL., GENE THER., vol. 23, no. 4, April 2016 (2016-04-01), pages 380 - 92
KIM H ET AL., CANCER GENE THER., vol. 23, 2016, pages 341 - 347
KITAGUCHI K ET AL., INT J MOL MED., vol. 16, no. 4, 2005, pages 683 - 8
KODIPPILI K ET AL., HUM GENE THER., 4 August 2017 (2017-08-04)
LIU GX, INT IMMUNOPHARMACOL., vol. 19, no. 1, March 2014 (2014-03-01), pages 145 - 52
LV F ET AL., CANCER LETT., vol. 302, no. 2, 2011, pages 119 - 27
MAYS LEWILSON JM, MOL THER., vol. 19, no. 1, 2011, pages 16 - 27
MENDELL JR ET AL., NEW ENGL J MED., vol. 363, no. 15, 2010, pages 1429 - 37
MUELLER C. ET AL., MOL THER., vol. 25, no. 6, June 2017 (2017-06-01), pages 1387 - 1394
NAT. BIOTECHNOL., vol. 32, 2014, pages 397
NELSON CE ET AL., SCIENCE, vol. 351, no. 6271, 2016, pages 403 - 7
SAMARANCH L ET AL., GENE THERAPY, vol. 24, 2017, pages 253 - 261
SURAWEERA ET AL., FRONTIERS IN ONCOLOGY, vol. 8, 2018, pages 92
THOMSEN GM ET AL., GENE THER., vol. 24, no. 4, April 2017 (2017-04-01), pages 245 - 252
WATANABE M ET AL., HUM GENE THER., vol. 19, no. 3, March 2008 (2008-03-01), pages 300 - 10
YU Z ET AL., J NEUROSCI METHODS, vol. 291, 2017, pages 69 - 82

Similar Documents

Publication Publication Date Title
GB202100827D0 (en) Method
GB202010104D0 (en) Method
GB202006815D0 (en) Method
GB202004944D0 (en) Method
GB202004863D0 (en) Method
GB202017861D0 (en) Method
GB202015993D0 (en) Method
GB202014709D0 (en) Method
GB202011823D0 (en) Method
GB202010922D0 (en) Method
GB202010046D0 (en) Method
GB202007044D0 (en) Method
GB202006047D0 (en) Method
GB202004515D0 (en) Method
GB202003580D0 (en) Method
GB202109503D0 (en) Method
GB202101188D0 (en) Method
GB202100365D0 (en) Method
GB202020180D0 (en) Method
GB202020183D0 (en) Method
GB202018514D0 (en) Method
GB202018262D0 (en) Method
GB202018125D0 (en) Method
GB202017725D0 (en) Method
GB202016334D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)